Bayer collaborates with Loxo Oncology on cancer medicine

16-11-2017

Bayer collaborates with Loxo Oncology on cancer medicine

CIPhotos / iStockphoto.com

Bayer has entered into a global collaboration with biopharmaceutical company Loxo Oncology, in a deal that could be worth more than $1 billion.


Loxo Oncology, Bayer, licence, patent, oncology, biotechnology, genetics, precision medicine, cancer


LSIPR